Clinical Trial Update: Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT

View source ↗

Summary

This is an ancillary analysis of the IDNT trial, reporting serum total homocysteine and C-reactive protein measurements in participants with cardiovascular dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Heart Disease
• Hypertension
• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Atherosclerosis | Status: COMPLETED